Contact us
Home / News Center / Business / Page 2

Business

Filters
Filters
Category
Search
Show (36)
Cancel
news7_Bora Pharmaceuticals_December 12, 2024_1523x510
Business

Bora Pharmaceuticals Wins Dual Honors at the Taiwan MAPECT M&A Ceremony: “Deal of the Year” Award and “Best Cross-Border M&A” Award

Bora Pharmaceuticals Wins Dual Honors at the Taiwan MAPECT M&A

news8_Bora Pharmaceuticals_October 25, 2024_1523x600
Business

Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals

Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),

tanvex
Business

Bora Pharmaceuticals Makes a Strategic Investment into Tanvex to Provide Global BioManufacturing Services.

Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),

news12_Bora Pharmaceuticals_August 20, 2024_1523x510
Business

Bora Completes Acquisition of US Sterile Fill/Finish Facility From Emergent

Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),

news14_Bora Recognized_July 8, 2024_1523x510
Business

Bora Recognized with Dual Accolades at Asia Best Companies to Work for Awards 2024

《HR Asia》, the leading HR magazine in Asia, recently announced
news15_Bora Pharmaceuticals_June 20, 2024_1523x510
Business

Bora Pharmaceuticals Expands North American Footprint with Agreement to Acquire First Sterile Manufacturing Facility

Bora Pharmaceuticals announced it entered into an agreement for Emergent
news16_Bora Wins_April 11, 2024_1523x510
Business

Bora Wins Presidential Innovation Award, Award Prize Donation to Benefit Those Impacted by Earthquake

The Office of the President Taiwan announced the winners of
news17_Bora Pharmaceuticals_April 2, 2024_1523x510
Business

Bora Pharmaceuticals Completes the Acquisition of Upsher-Smith

Bora Pharmaceuticals announced it has completed the acquisition of Upsher-Smith
news18_SunWay Biotech_March 18, 2024_1523x510
Business

SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient

SunWay Biotech and Gnosis by Lesaffre has announced a strategic
Upsher-Smith
Business

Bora Pharmaceuticals to Acquire US Pharma Manufacturer Upsher-Smith for $210 Million in Transaction to Fuel Global Expansion

Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),
news21_Bora Pharmaceuticals_December 11, 2023_1523x510
Business

Bora Pharmaceuticals Celebrates Integration with SunWay Biotech, Embarking on a Global Journey

Taipei, Taiwan - December 11, 2023 – Last Friday, Bora
news13_Bora Recognized_December 8, 2023_1523x510
Business

Bora Recognized at “2023 Most Outstanding Company of the Year Awards.” Ceremony Attended by President Tsai Ing-wen

Bora Pharmaceuticals honored at the "2023 Most Outstanding Company of